Loading clinical trials...

Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies | Clinical Trials | Clareo Health

UNKNOWNNCT05598788

Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

The MISTIK project aims at clinically validating the technique of oral anticancer drugs determination by volumetric absorptive micro-sampling and at comparing the results to measurements performed on ...

Lead sponsor: Rennes University Hospital•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ferragu Cécile

CONTACT

0299282555 cecile.ferragu@chu-rennes.fr

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment360

Start dateMar 2023

Last updatedMay 3, 2023

Locations shown

Centre Eugène Marquis Unicancer

Rennes

Rennes University Hospital

Rennes

Institut de cancérologie Strasbourg Europe

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions